AIP
HLF icon

Almanack Investment Partners’s Herbalife HLF Stock Holding History

Almanack Investment Partners’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60
Closed -$1K – 608
2022
Q3 		$1K Buy
+60
New +$1.49K ﹤0.01% 805

Other funds holding HLF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $10.1B AUM 10.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return

Almanack Investment Partners's HLF Position: Q4 2022 in Review

Almanack Investment Partners sold out of Herbalife (HLF) in Q4 2022, closing a stake of 60 shares — an estimated $1K sold.

Almanack Investment Partners first reported a position in HLF in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 216 funds tracked by Wall St. Rank hold HLF as of Q4 2022.

  • Almanack Investment Partners reported no remaining Herbalife position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 60 Herbalife shares in Q4 2022, an estimated $1K.
  • Almanack Investment Partners first reported a position in Herbalife in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's Herbalife position peaked at $1K in Q3 2022.
  • 216 funds tracked by Wall St. Rank held Herbalife as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.